Plastomics Raises $5.8M in Initial Close of Series B

Why It Matters

Chloroplast engineering promises higher‑yield, climate‑resilient crops, and the new capital positions Plastomics to fast‑track these innovations, potentially reshaping the agricultural biotech landscape and attracting further investment.

Deal Summary

Plastomics, an agricultural biotechnology company based in St. Louis, announced an initial $5.8M close of its Series B to accelerate development of transgenic chloroplast traits. Backers include Fulcrum Global Capital, Lewis & Clark Partners, Skull Diamond and Heart Capital, Missouri Technology Corporation, and BioGenerator Ventures.